StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nuvation Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$120.52M. For fiscal 2025 it was -$173.43M. The highest annual figure on record is -$36.53M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$173.43M–
FY2024Dec 31, 2024-$130.41M–
FY2023Dec 31, 2023-$68.00M–
FY2022Dec 31, 2022-$96.11M–
FY2021Dec 31, 2021-$68.19M–
FY2020Dec 31, 2020-$36.53M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$42.97M–
Q1 FY2026Mar 31, 2026$5.07M–
Q4 FY2025Dec 31, 2025-$29.73M–
Q3 FY2025Sep 30, 2025-$52.89M–
Q2 FY2025Jun 30, 2025-$48.18M–
Q1 FY2025Mar 31, 2025-$42.63M–
Q4 FY2024Dec 31, 2024-$46.30M–
Q3 FY2024Sep 30, 2024-$31.09M–
Q2 FY2024Jun 30, 2024-$37.32M–
Q1 FY2024Mar 31, 2024-$15.70M–
Q4 FY2023Dec 31, 2023-$15.03M–
Q3 FY2023Sep 30, 2023-$16.16M–
Q2 FY2023Jun 30, 2023-$17.49M–
Q1 FY2023Mar 31, 2023-$19.33M–
Q4 FY2022Dec 31, 2022-$16.17M–
Q3 FY2022Sep 30, 2022-$28.09M–
Q2 FY2022Jun 30, 2022-$26.92M–
Q1 FY2022Mar 31, 2022-$24.93M–
Q4 FY2021Dec 31, 2021-$23.48M–
Q3 FY2021Sep 30, 2021-$13.15M–
Q2 FY2021Jun 30, 2021-$16.83M–
Q1 FY2021Mar 31, 2021-$14.73M-269.0%
Q4 FY2020Dec 31, 2020-$12.94M–
Q3 FY2020Sep 30, 2020-$8.04M–
Q2 FY2020Jun 30, 2020-$24.27M–
Q1 FY2020Mar 31, 2020$8.72M–

More Nuvation Bio figures

See a number that looks wrong?